Wellnex Life (ASX:WNX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Wellnex Life.
RELATED STOCKHEAD STORIES
Lunch Wrap: Bulls back in control after US-China truce; tech, commodities rally
Biocurious: Sometimes an effective therapy lies not just with the drug, but how it is delivered
Wellnex directors commit to $1.5 million in entitlement offer ahead of London listing
Closing Bell: ASX sinks as soft earnings melt hopes; Fortescue and Magellan hit hard
London calling: Wellnex Life secures $14.3 million for LSE listing
Wellnex Life secures $9m to propel dual listing on London’s AIM market
Vital Signs Podcast: Wellnex Life takes on London
Biocurious: Consumer health minnow Wellnex Life gears up for company-making Eurotrip
Wellnex Secures TGA approval for Liquid Paracetamol plus Caffeine Soft Gel as it targets growth opportunities
Wellnex ready for dual UK listing in new year after record November sales
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
Closing Bell: Telix, banks lift ASX; but Newmont and Fortescue trip over soaring costs
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
